Drugs and Devices
- Section 10350 - Labeling Defined (26207) [Repealed]
- Section 10355 - Truth of Labeling (26208) [Repealed]
- Section 10360 - New Drugs -Definition
- Section 10365 - Drugs - Name (26230) [Repealed]
- Section 10370 - Poisonous Insecticides and Rodenticides, Use of (26234(2)) [Repealed]
- Section 10371 - Drugs: Current Good Manufacturing Practice in Manufacture, Processing, Packaging, Labeling or Holding (26234(3)) [Repealed]
- Section 10375 - Blending of Certified Coal Tar Colors (26235 (2)) [Repealed]
- Section 10376 - Drug and Device Manufacturing Licenses
- Section 10377 - Definitions
- Section 10377.1 - Qualifications
- Section 10377.2 - Revocation and Suspension
- Section 10377.3 - Compliance
- Section 10377.4 - Requirements for the Storage and Handling of Human Prescription Drugs
- Section 10377.5 - Requirements for the Establishment and Maintenance of Human Prescription Drug Records
- Section 10377.6 - Written Policies and Procedures for the Handling of Human Prescription Drugs
- Section 10377.7 - Inspection by Federal, State, and Local Law Enforcement Officials
- Section 10377.8 - Manufacturers of Active Ingredient Components of Human Prescription Drugs
- Section 10380 - Labeling, Misbranding (26240) [Repealed]
- Section 10381 - Label Non-Prescription Drugs. Pregnancy/Nursing
- Section 10385 - Labeling Requirements (26241) [Repealed]
- Section 10386 - Manufacturer of Finished Dosage Form
- Section 10390 - Forms of Making Required Statements (26242) [Repealed]
- Section 10395 - Statements of Ingredients and Proportions (26243) [Repealed]
- Section 10400 - Hoxsey Method for Treatment of Cancer
- Section 10400.1 - Beta-Cyanogenetic Glucosides ( "Laetriles") Agent for Treatment of Cancer
- Section 10400.2 - Bolen Test for Diagnosis of Cancer
- Section 10400.3 - Koch Agents for Treatment of Cancer
- Section 10400.4 - Lincoln Staphage Lysate Agent for Treatment of Cancer
- Section 10400.5 - Mucorhicin Agent for Treatment of Cancer
- Section 10400.6 - Anthrone Test for Diagnosis of Cancer
- Section 10400.7 - Krebiozen for Treatment of Cancer
- Section 10401 - Drugs for Use in the Diagnosis, Treatment, Alleviation or Cure of Cancer in Human Beings [Repealed]
- Section 10401.1 - Investigation of Various Agents for the Diagnosis or Treatment of Cancer
- Section 10401.2 - American Board of Oncology [Repealed]
- Section 10405 - Directions for Use -Exemptions Thereto
- Section 10409 - Prescription Ophthalmic Devices
- Section 10410 - Exemption for Prescription Devices
- Section 10415 - Exemption for Prescription Drugs and Veterinary Drugs
- Section 10416 - Exemptions for Drugs Dispensed by Licensed Practitioners [Repealed]
- Section 10417 - Formulary of Inequivalent Generic Drug Types and Drug Products for Which Substitution Poses a Threat to Health and Safety
- Section 10420 - Label Requirements (26254) [Repealed]